Press Release

Cooley Advises Underwriters on TetraLogic Initial Public Offering

December 26, 2013

Palo Alto, Calif. – December 26, 2013 – Cooley LLP announced today that it advised the underwriters on TetraLogic Pharmaceuticals, Corp.'s initial public offering. TetraLogic, a biopharmaceutical company that focuses on the discovery and development of Smac mimetics, now trades on the NASDAQ Global Market under the symbol "TLOG."

Underwriters for the offering include Oppenheimer & Co., Guggenheim Securities, and Needham & Company.

The Cooley corporate securities team advising the underwriters was led by partner Brent Siler and included partner Drew Williamson, special counsel Brian Leaf and associate Robert E. Jones. Critical support for the offering was provided by Natasha Leskovsek (FDA regulatory) and Bill Christiansen (intellectual property).

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 700 lawyers across eleven offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.